Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial.

[1]  N. Weissman,et al.  A paclitaxel-eluting stent for the prevention of coronary restenosis. , 2003, The New England journal of medicine.

[2]  A. Yıldırır,et al.  Carbon Coating of Stents Has No Effect on Inflammatory Response to Primary Stent Deployment , 2002, Angiology.

[3]  R. Erbel,et al.  Stent Coating: A New Approach in Interventional Cardiology , 2002, Herz.

[4]  G. Mintz,et al.  Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound. , 2002, The American journal of cardiology.

[5]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[6]  M. Jeong,et al.  Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease. , 2002, The American journal of cardiology.

[7]  D. Trabattoni,et al.  Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent™: The Antares study , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  D. Antoniucci,et al.  Clinical and angiographic outcomes following elective implantation of the carbostent in patients at high risk of restenosis and target vessel failure , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  H. Wichmann,et al.  Epidemiology of contact allergy in adults , 2001, Allergy.

[10]  T. Meinertz,et al.  Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis , 2000, The Lancet.

[11]  C. Beythien,et al.  In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. , 2000, Thrombosis research.

[12]  D. Antoniucci,et al.  Clinical and angiographic outcome after coronary arterial stenting with the carbostent. , 2000, The American journal of cardiology.

[13]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[14]  R. Virmani,et al.  Pathology of acute and chronic coronary stenting in humans. , 1999, Circulation.

[15]  M. Leon,et al.  In-stent restenosis: the Washington Hospital Center experience. , 1998, The American journal of cardiology.

[16]  E. Topol,et al.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. , 1996, Circulation.

[17]  E. Edelman,et al.  Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.

[18]  G. Bocchiotti,et al.  Carbofilm‐Covered Prostheses in Plastic Surgery: Preliminary Observations , 1993, Plastic and reconstructive surgery.

[19]  D. Williams,et al.  Stimulation of neutrophil movement by metal ions. , 1992, Journal of biomedical materials research.

[20]  M. Mooney,et al.  Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. , 1991, The American journal of cardiology.

[21]  R. de Caterina,et al.  Pyrolytic Carbon Coating Enhances Teflon and Dacron Fabric Compatibility with Endothelial cell Growth , 1991, The International journal of artificial organs.

[22]  M. Leon,et al.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. , 1998, Journal of the American College of Cardiology.

[23]  G. Ciapetti,et al.  Adhesive protein expression on endothelial cells after contact in vitro with polyethylene terephthalate coated with pyrolytic carbon. , 1995, Biomaterials.

[24]  P. Aebischer,et al.  Tissue reaction to fabrics coated with turbostratic carbon: subcutaneous versus vascular implants. , 1988, Biomaterials.